Relationship Between Duration of Targeted Temperature Management, Ischemic Interval, and Good Functional Outcome From Out-of-Hospital Cardiac Arrest

Supplemental Digital Content is available in the text. Objectives: Tailoring hypothermia duration to ischemia duration may improve outcome from out-of-hospital cardiac arrest. We investigated the association between the hypothermia/ischemia ratio and functional outcome in a secondary analysis of data from the Resuscitation Outcomes Consortium Amiodarone, Lidocaine, or Placebo Study trial. Design: Cohort study of out-of-hospital cardiac arrest patients screened for Resuscitation Outcomes Consortium-Amiodarone, Lidocaine, or Placebo Study. Setting: Multicenter study across North America. Patients: Adult, nontraumatic, out-of-hospital cardiac arrest patients screened for Resuscitation Outcomes Consortium-Amiodarone, Lidocaine, or Placebo Study who survived to hospital admission and received targeted temperature management between May 2012 and October 2015. Interventions: Targeted temperature management in comatose survivors of out-of-hospital cardiac arrest. We defined hypothermia/ischemia ratio as total targeted temperature management time (initiation through rewarming) divided by calculated total ischemia time (approximate time of arrest [9-1-1 call or emergency medical services-witnessed] to return of spontaneous circulation). Measurements and Main Results: The primary outcome was hospital survival with good functional status (modified Rankin Score, 0–3) at hospital discharge. We fitted logistic regression models to estimate the association between hypothermia/ischemia ratio and the primary outcome, adjusting for demographics, arrest characteristics, and Resuscitation Outcomes Consortium enrolling site. A total of 3,429 patients were eligible for inclusion, of whom 36.2% were discharged with good functional outcome. Patients had a mean age of 62.0 years (sd, 15.8), with 69.7% male, and 58.0% receiving lay-rescuer cardiopulmonary resuscitation. Median time to return of spontaneous circulation was 21.1 minutes (interquartile range, 16.1–26.9), and median duration of targeted temperature management was 32.9 hours (interquartile range, 23.7–37.8). A total of 2,579 had complete data and were included in adjusted regression analyses. After adjustment for patient characteristics and Resuscitation Outcomes Consortium site, a greater hypothermia/ischemia ratio was associated with increased survival with good functional outcome (odds ratio, 2.01; 95% CI, 1.82–2.23). This relationship, however, appears to be primarily driven by time to return of spontaneous circulation in this patient cohort. Conclusions: Although a larger hypothermia/ischemia ratio was associated with good functional outcome after out-of-hospital cardiac arrest in this cohort, this association is primarily driven by duration of time to return of spontaneous circulation. Tailoring duration of targeted temperature management based on duration of time to return of spontaneous circulation or patient characteristics requires prospective study.

[1]  Jan Potter,et al.  Reliability of the Modified Rankin Scale Across Multiple Raters: Benefits of a Structured Interview , 2005, Stroke.

[2]  R. Neumar,et al.  Post–Cardiac Arrest Syndrome Epidemiology, Pathophysiology, Treatment, and Prognostication A Consensus Statement From the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Strok , 2008 .

[3]  A. Rossetti,et al.  Early Multimodal Outcome Prediction After Cardiac Arrest in Patients Treated With Hypothermia* , 2014, Critical care medicine.

[4]  An observational study of patient selection criteria for post-cardiac arrest therapeutic hypothermia. , 2013, Resuscitation.

[5]  M. Holzer,et al.  Relationship between time to target temperature and outcome in patients treated with therapeutic hypothermia after cardiac arrest , 2011, Critical care.

[6]  J. López-Sendón,et al.  Hypothermia in Comatose Survivors From Out-of-Hospital Cardiac Arrest: Pilot Trial Comparing 2 Levels of Target Temperature , 2012, Circulation.

[7]  M. Wise,et al.  Targeted temperature management at 33°C versus 36°C after cardiac arrest. , 2013, The New England journal of medicine.

[8]  S. Bernard,et al.  Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. , 2002, The New England journal of medicine.

[9]  Graham Nichol,et al.  Rationale, development and implementation of the Resuscitation Outcomes Consortium Epistry-Cardiac Arrest. , 2008, Resuscitation.

[10]  Karen Smith,et al.  Treatment of Comatose Survivors of Out-of-hospital Cardiac Arrest With Induced Hypothermia , 2003 .

[11]  Alessio Farcomeni,et al.  Predictors of poor neurological outcome in adult comatose survivors of cardiac arrest: a systematic review and meta-analysis. Part 2: Patients treated with therapeutic hypothermia. , 2013, Resuscitation.

[12]  W. K. Lindsay,et al.  Hypothermia; its possible role in cardiac surgery: an investigation of factors governing survival in dogs at low body temperatures. , 1950, Annals of surgery.

[13]  D. Verhaert,et al.  Hemodynamic targets during therapeutic hypothermia after cardiac arrest: A prospective observational study. , 2015, Resuscitation.

[14]  P. Kudenchuk,et al.  Resuscitation Outcomes Consortium-Amiodarone, Lidocaine or Placebo Study (ROC-ALPS): Rationale and methodology behind an out-of-hospital cardiac arrest antiarrhythmic drug trial. , 2014, American heart journal.

[15]  Christian Storm,et al.  Targeted Temperature Management for 48 vs 24 Hours and Neurologic Outcome After Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial , 2017, JAMA.

[16]  Mary Ann Peberdy,et al.  Part 8: Post–Cardiac Arrest Care 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care , 2015, Circulation.

[17]  R. Neumar,et al.  Combined intra- and post-cardiac arrest hypothermic-targeted temperature management in a rat model of asphyxial cardiac arrest improves survival and neurologic outcome compared to either strategy alone. , 2016, Resuscitation.

[18]  Dong Hun Lee,et al.  Combining brain computed tomography and serum neuron specific enolase improves the prognostic performance compared to either alone in comatose cardiac arrest survivors treated with therapeutic hypothermia. , 2013, Resuscitation.

[19]  B. Abella,et al.  Shorter time to target temperature is associated with poor neurologic outcome in post-arrest patients treated with targeted temperature management. , 2015, Resuscitation.

[20]  Michael Holzer,et al.  Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest , 2002 .

[21]  Marek Czosnyka,et al.  Using the relationship between brain tissue regional saturation of oxygen and mean arterial pressure to determine the optimal mean arterial pressure in patients following cardiac arrest: A pilot proof-of-concept study. , 2016, Resuscitation.

[22]  Alan D. Lopez,et al.  Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. , 2002, The New England journal of medicine.

[23]  T. Ala-Kokko,et al.  Mean arterial pressure and vasopressor load after out-of-hospital cardiac arrest: Associations with one-year neurologic outcome. , 2016, Resuscitation.

[24]  R. Elswick,et al.  An investigation of a hypothermic to ischemic ratio in patients following out-of-hospital cardiac arrest presenting with a shockable rhythm. , 2014, Therapeutic hypothermia and temperature management.

[25]  M. Fornage,et al.  Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.

[26]  R. Neumar,et al.  Impact of therapeutic hypothermia onset and duration on survival, neurologic function, and neurodegeneration after cardiac arrest* , 2011, Critical care medicine.

[27]  C. Callaway,et al.  Predicting survival after out-of-hospital cardiac arrest: role of the Utstein data elements. , 2010, Annals of Emergency Medicine.

[28]  C. Callaway,et al.  Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The ALPS Study (Amiodarone, Lidocaine, or Placebo) , 2017, Circulation.

[29]  John E Billi,et al.  Cardiac arrest and cardiopulmonary resuscitation outcome reports: update and simplification of the Utstein templates for resuscitation registries: a statement for healthcare professionals from a task force of the International Liaison Committee on Resuscitation (American Heart Association, European , 2004, Circulation.